Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.

[1]  A. Luini,et al.  Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. , 2013, The Lancet. Oncology.

[2]  K. Hunt,et al.  Positive sentinel nodes without axillary dissection: implications for the radiation oncologist. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. Giuliano,et al.  Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. , 2011, JAMA.

[4]  S. Fosså,et al.  The relation between arm/shoulder problems and quality of life in breast cancer survivors: a cross-sectional and longitudinal study , 2010, Journal of cancer survivorship : research and practice.

[5]  Kelly K. Hunt,et al.  Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. , 2010, Annals of surgery.

[6]  T. Julian,et al.  Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Norman Wolmark,et al.  Morbidity results from the NSABP B‐32 trial comparing sentinel lymph node dissection versus axillary dissection , 2010, Journal of surgical oncology.

[8]  E. Rutgers,et al.  UvA-DARE ( Digital Academic Repository ) Sentinel Node Identification Rate and Nodal Involvement in the EORTC 10981-22023 AMAROS , 2010 .

[9]  A. Soran,et al.  Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[10]  I. V. D. van der Ploeg,et al.  Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: A systematic review and meta-analysis of the literature. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[11]  Barbara L. Smith,et al.  Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  M. Begovic,et al.  The incidence of arm edema in women with breast cancer randomized on the National Surgical Adjuvant Breast and Bowel Project study B-04 to radical mastectomy versus total mastectomy and radiotherapy versus total mastectomy alone. , 2004, International journal of radiation oncology, biology, physics.

[13]  Kelly K Hunt,et al.  Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  P. Fayers,et al.  The clinical significance of adaptation to changing health: A meta-analysis of response shift , 2006, Quality of Life Research.

[15]  U. Chetty,et al.  Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. , 2006, Journal of the National Cancer Institute.

[16]  R. Newcombe,et al.  Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer , 2006, Breast Cancer Research and Treatment.

[17]  Elizabeth H. Wood,et al.  The National Comprehensive Cancer Network (NCCN). , 2004 .

[18]  Mark C Kelley,et al.  Lymphatic mapping and sentinel lymphadenectomy for breast cancer. , 2004, American journal of surgery.

[19]  B. Asselain,et al.  Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  E. Rutgers,et al.  Quality assurance of axillary radiotherapy in the EORTC AMAROS trial 10981/22023: the dummy run. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  Umberto Veronesi,et al.  A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. , 2003, The New England journal of medicine.

[22]  Jong-Hyeon Jeong,et al.  Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. , 2002, The New England journal of medicine.

[23]  E. Rutgers,et al.  The European Organization for Research and Treatment of Cancer (EORTC) Breast Cancer Group: quality control of surgical trials. , 2001, Surgical oncology clinics of North America.

[24]  S. Ménard,et al.  Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis. , 2000, Annals of surgery.

[25]  A. Hart,et al.  Primary axillary radiotherapy as axillary treatment in breast‐conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes , 2000, Cancer.

[26]  D. Osoba,et al.  Interpreting the significance of changes in health-related quality-of-life scores. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  B. Asselain,et al.  Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer , 1992, The Lancet.